![]() |
市場調查報告書
商品編碼
1467783
2024-2032 年按產品類型、攜帶性、最終用戶、應用和地區分類的霧化器市場報告Nebulizers Market Report by Product Type, Portability, End-User, Application, and Region 2024-2032 |
2023年全球霧化器市場規模達14IMARC Group美元。
霧化器是患有呼吸系統疾病的患者用來將藥物直接注射到肺部的設備。這些裝置通常由馬達、吸嘴、杯子和管道組成,利用氧氣、壓縮空氣或超音波功率將液體藥物分解成氣霧劑,將液體藥物變成細霧。醫生開處方給使用吸入器時無法深呼吸的人。霧化器主要用於緩解極端呼吸狀況,例如慢性阻塞性肺病(COPD)、氣喘、囊性纖維化等。
慢性呼吸道疾病盛行率上升是推動市場成長的主要因素。繁忙的日程、久坐的生活方式和缺乏體力活動導致全球肥胖率上升。這與菸草和酒精消費量的增加相結合,極大地導致了呼吸系統疾病的發生率增加,從而促進了霧化器的銷售。除此之外,由於私家車的使用增加和工業擴張而導致的污染程度上升是影響全球產品需求的另一個關鍵因素。此外,老年人口的成長導致對家庭醫療保健設備的需求增加,從而推動了對攜帶式設備的需求。此外,一些組織正在採取舉措,提高人們對呼吸系統疾病可用治療方案的認知。例如,慢性阻塞性肺病全球計劃 (GOLD) 正在積極向公眾宣傳慢性阻塞性肺病帶來的風險及其治療方法。
The global nebulizers market size reached US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
Nebulizers are devices that are used by patients suffering from respiratory diseases to administer the medication directly into the lungs. Usually made up of a motor, mouthpiece, cup and tubing, these devices turn liquid medicine into a fine mist by using oxygen, compressed air or ultrasonic power for breaking up the liquid drug into aerosols. They are prescribed by doctors to people who are unable to breathe deeply while using an inhaler. Nebulizers are primarily utilized for providing relief from extreme breathing conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, etc.
Rising prevalence of chronic respiratory diseases is a major factor boosting the growth of the market. Busy schedules, sedentary lifestyles and a lack of physical activities have led to an increase in prevalence of obesity across the globe. This, in confluence with escalating consumption of tobacco and alcohol, is significantly contributing to the increasing occurrence of respiratory disorders, thereby bolstering the sales of nebulizers. Apart from this, rising pollution levels on account of increasing adoption of private vehicles and expansion of industries is another key factor that is contributing to the product's demand globally. Moreover, the growing geriatric population has led to an increase in the demand for home healthcare devices, which is driving the demand for portable variants. Furthermore, several organizations are taking initiatives to spread awareness about the available treatment options for respiratory diseases. For instance, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) is actively educating the public about the risks posed by COPD and the treatment of the same.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nebulizers market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, portability, end-user and application.
Pneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Others
Portable Nebulizers
Standalone Nebulizers
Hospitals and Clinics
Long Term Healthcare Centers
Homecare Settings
Outpatient Settings
COPD
Cystic Fibrosis
Asthma
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc. and Graham Field (GF) Health Products, Inc.